Angelina Jolie's announcement that she is a BRCA1 carrier and has had a prophylactic bilateral mastectomy was met with widespread support as well as speculation about its possible impact on the public. These speculations were the subject of a Time magazine cover story titled “The Angelina Effect” (Kluger et al., 2013 Jolie, A. (2013, May 14). My medical choice. Retrieved from The New York Times website: http://www.nytimes.com/2013/05/14/opinion/my-medical-choice.html?_r=0 [Google Scholar]). Although there is anecdotal evidence to support this hypothesized Angelina effect, empirical tests are lacking. To explore possible links between Angelina's announcement and public health, we surveyed 356 adults immediately after the announcement. Guided by a model of celebrity influence, the survey assessed participants’ demographics and health history, identification and parasocial interaction with Jolie, and genetic testing intentions. Results supported the model's predictions and provided preliminary evidence of an Angelina effect.
No takes yet. Share an insight, caveat, or question.
Kosenko et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: